✦ LIBER ✦

Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist

✍ Scribed by Paul L. M. van Giersbergen; Jasper Dingemanse

Book ID: 105921340
Publisher: Springer
Year: 2006
Tongue: English
Weight: 144 KB
Volume: 63
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-006-0117-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, Pharmacodynamics, and

Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist

✍ Lai, E; Wenning, LA; Crumley, TM; De Lepeleire, I; Liu, F; de Hoon, JN; Van Heck 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 348 KB

Tolerability and pharmacokinetics of L-6

Tolerability and pharmacokinetics of L-648,051. A leukotriene D4-receptor antagonist, in healthy volunteers

✍ J. Biollaz; E. Stahl; J. Y. Hsieh; L. Distlerath; A. Jaeger; Ph. Leuenberger; J. 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 566 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers

✍ B. Jansen; U. Graselli; S. Dallinger; B. Kiss; V. Wacheck; H. Schlagbauer-Wadl; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 103 KB

Pharmacodynamics and pharmacokinetics of

Pharmacodynamics and pharmacokinetics of YM128, a GPIIb/IIIa antagonist prodrug

✍ Ken-ichi Suzuki; Yumiko Moritani; Nami Hisamichi; Masato Ichihara; Seijiro Akama 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

Pharmacokinetics, pharmacodynamics, tole

Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12receptor antagonist, in healthy subjects

✍ Renli Teng; Kathleen Butler 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 224 KB

A review of the pharmacokinetics, tolera

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers

✍ P. Rosenzweig; M. Canal; A. Patat; L. Bergougnan; I. Zieleniuk; G. Bianchetti 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Amisulpride binds selectively to dopamine D(2) and D(3) receptors in the limbic system. Low doses of amisulpride preferentially block presynaptic D(2)/D(3)-dopamine autoreceptors, thereby enhancing dopaminergic transmission, whereas higher doses block postsynaptic receptors, thus inhibiting dopamine